Cargando…
After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents
Genetic testing is becoming more common and more powerful by the day. The costs of the underlying DNA sequencing technology are plummeting, making it likely that tests based on it will become even more pervasive. The use of tests to determine DNA sequence to help make clinical decisions is here to s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225052/ https://www.ncbi.nlm.nih.gov/pubmed/25401053 http://dx.doi.org/10.1007/s40142-014-0055-5 |